Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 228

Results For "PLI"

2779 News Found

Prof. Jason Kovacic bags Agilent Thought Leader award
News | January 11, 2022

Prof. Jason Kovacic bags Agilent Thought Leader award

Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease


Intuitive India launches Intuitive Telepresence for remote surgical case observation
Digitisation | January 11, 2022

Intuitive India launches Intuitive Telepresence for remote surgical case observation

Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel


We achieved 40% revenue growth in 2021: Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals
interviews | January 10, 2022

We achieved 40% revenue growth in 2021: Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals

The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry


Novartis and Molecular Partners report positive data for anti-viral Covid therapy
Biotech | January 10, 2022

Novartis and Molecular Partners report positive data for anti-viral Covid therapy

Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days


Odisha is the first state to place order for OmiSure to detect Omicron
Medical Device | January 10, 2022

Odisha is the first state to place order for OmiSure to detect Omicron

TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant


Alembic receives tentative U.S.FDA approval for dronedarone tablets
Drug Approval | January 10, 2022

Alembic receives tentative U.S.FDA approval for dronedarone tablets

Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA


Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform
News | January 10, 2022

Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform

Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation


Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report
News | January 10, 2022

Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma


Bayer and Mammoth Biosciences to collaborate on gene editing technology
Biotech | January 10, 2022

Bayer and Mammoth Biosciences to collaborate on gene editing technology

Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones


Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics
Biotech | January 10, 2022

Moderna and Carisma Therapeutics partner to develop CAR-M therapeutics

Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note